Ausgabe 1/2022
Inhalt (32 Artikel)
Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review
Paola Ghanem, Kristen Marrone, Satish Shanbhag, Julie R. Brahmer, Rakhi P. Naik
Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis
Pallavi Patwardhan, Adrienne Landsteiner, Lincy S. Lal, Lincy Geevarghese, Lisa Le, Savita Nandal, Adam Cuker
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction
Mitchell Davis, Mohammad Reza Movahed, Mehrtash Hashemzadeh, Mehrnoosh Hashemzadeh
miRNA profile and disease severity in patients with sickle cell anemia
Thaís Priscila Biassi, Elvira Maria Guerra-Shinohara, Patrícia Natália Silva Moretti, Valeria de Freitas Dutra, Ana Carolina Cabañas-Pedro, Grazielle Mecabo, Gisele Wally Braga Colleoni, Maria Stella Figueiredo
Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome
Nazim Yildirim, Selma Unal, Ahmet Yalcinkaya, Feryal Karahan, Yesim Oztas
Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study
Albraa Abulhamail, Ahmad AlShebli, Leeena Merdad, Siraj Wali, Wasil Jastaniah, Bahaa Abaalkhail
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
Julio del Río-Garma, Sabela Bobillo, Javier de la Rubia, Cristina Pascual, Faustino García-Candel, Jose M. García-Gala, Reyes Gonzalez, Laura Abril, Julia Vidan, Maria Jesús Gomez, Francisco Peña, Cristina Arbona, Jesús Martín-Sanchez, Gemma Moreno, Iñigo Romón, Aurora Viejo, Ana Oliva, Mónica Linares, Ramón Salinas, Sonia Pérez, Jose A. Garcia-Erce, Arturo Pereira
Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India
Anshul Gupta, Nihar Desai, Sanjeev, Priyanka Chauhan, Soniya Nityanand, Zia Hashim, Mansi Gupta
Ixazomib, lenalidomide, and dexamethasone combination in “real-world” clinical practice in patients with relapsed/refractory multiple myeloma
Juraj Sokol, Tomas Guman, Juraj Chudej, Monika Hlebaskova, Natalia Stecova, Lubica Valekova, Monika Kucerikova, Jan Stasko
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma
Xiaojun Wang, Yi Miao, Zheng Cao, Shan Zheng, Xuemin Xue, Xiaoli Feng
Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease
Ryan C. W. Ho, Thomas S. Y. Chan, Rex Au-Yeung, Karen H. K. Tang, Yu-Yan Hwang, Eric Tse, Yok-Lam Kwong
Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015
Hsin-An Hou, Huey-En Tzeng, Hung-Yi Liu, Wen-Chien Chou, Hwei-Fang Tien, Li-Nien Chien
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
Peng Zhao, Ming Ni, Dan Ma, Qin Fang, Yan Zhang, Yanju Li, Yi Huang, Ying Chen, Xiao Chai, Yun Zhan, Yan Li, Qian Kang, Mei Zhao, Min Liu, Fengqi Zhang, Shisi Huang, Shuangshuang Wen, Bo Deng, Jishi Wang
Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval
Srdan Verstovsek, Shreekant Parasuraman, Jingbo Yu, Anne Shah, Shambhavi Kumar, Ann Xi, Claire Harrison
Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data
Andrew T. Kuykendall, Libo Sun, John Mascarenhas, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Julia Wang, Qi Xia, Eugene Zhu, Faye Feller, Aleksandra Rizo, Jacqueline Bussolari, Ying Wan, Rami Komrokji
Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting
Fernanda Rodrigues Mendes, Wellington Fernandes da Silva, Raphael da Costa Bandeira de Melo, Douglas Rafaele Almeida Silveira, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha, Eduardo Magalhaes Rego
Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre
Garret M. K. Leung, Joycelyn P. Y. Sim, Yu-Yan Hwang, Thomas S. Y. Chan, Albert K. W. Lie, Eric Tse, Yok-Lam Kwong
Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation
Nobuhiro Hiramoto, Hirohito Yamazaki, Yukinori Nakamura, Naoyuki Uchida, Makoto Murata, Tadakazu Kondo, Satoshi Yoshioka, Tetsuya Eto, Akinori Nishikawa, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Onishi, Ritsuro Suzuki, Takehiko Mori
Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies
Takaaki Konuma, Jun Ooi, Hitomi Nagayama, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Toshiro Kawakita, Masamichi Isobe, Maki Monna-Oiwa, Arinobu Tojo, Tohru Iseki, Satoshi Takahashi
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study
Małgorzata Salamonowicz-Bodzioch, Jowita Frączkiewicz, Krzysztof Czyżewski, Olga Zając-Spychała, Ewa Gorczyńska, Grażyna Wróbel, Bernarda Kazanowska, Dorota Sęga-Pondel, Jadwiga Węcławek-Tompol, Marek Ussowicz, Krzysztof Kałwak, Mariusz Wysocki, Magdalena Dziedzic, Jacek Wachowiak, Agnieszka Zaucha-Prażmo, Jerzy Kowalczyk, Jolanta Goździk, Jan Styczyński
Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study
Khaled M. Musallam, Maria Domenica Cappellini, Shahina Daar, Ali T. Taher
Dose-adjusted high-dose chemotherapy with autologous stem cell transplantation for elderly (≥ 70 years old) lymphoma patients
Hiroki Hosoi, Shogo Murata, Toshiki Mushino, Shinobu Tamura, Takashi Sonoki
Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study
Satoshi Yamasaki, Takumi Matsushima, Mariko Minami, Masanori Kadowaki, Ken Takase, Hiromi Iwasaki
Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib
Fernando Martín-Moro, Mónica García-Cosío, Juan Marquet-Palomanes, María López-Gutiérrez, Héctor Pian-Arias, Francisco Javier López-Jiménez
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
Sebastian Schlaweck, Peter Brossart, Annkristin Heine
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail
Pierre-Edouard Debureaux, Mathilde Ruggiu, Stéphanie Mathis, Adrien Mirouse, Bedis Dhouaieb, Wendy Cuccuini, Jean Soulier, Eric Mariotte, Pierre Lemaire
CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma
Harinder Gill, Rex Au-Yeung, Florence Loong, Yok-Lam Kwong
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia
Gloria Acquaviva, Giovanna Nonne, Andrea Murtas, Francesco Longu, Giovanni Caocci, Giorgio La Nasa, Claudio Fozza
HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19
Luca Roncati, Antonio Manenti, Luca Fabbiani, Claudia Malagoli, Vincenzo Nasillo, Beatrice Lusenti, Massimo Lupi, Giuliana Zanelli, Tiziana Salviato, Matteo Costantini, Tommaso Trenti, Antonio Maiorana
The first case of a collision tumor of gastrointestinal stromal tumor and intravascular large B cell lymphoma
Yueying Yuan, En-Hua Wang, Liang Wang
Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies
Masatoshi Sakurai, Yasuhito Nannya, Rie Yamazaki, Kentaro Yamaguchi, Yuya Koda, Ryohei Abe, Kenji Yokoyama, Seishi Ogawa, Takehiko Mori
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds
Immacolata Tartaglione, Renzo Manara, Rosanna di Concilio, Antonella Quarta, Giovan Battista Ruffo, Elisa De Michele, Federica Ammendola, Maria Vittoria Foderini, Simona Raimo, Gabriella Santangelo, Silverio Perrotta